AI In Clinical Trials Global Market Report 2025

Description

AI in clinical trials involves the application of artificial intelligence (AI) technologies and techniques in the planning, design, execution, and analysis of clinical trials. Clinical trials are rigorous research studies that assess the safety and effectiveness of medical interventions, such as new drugs, medical devices, or treatment protocols, in human subjects.

The primary offerings for AI in clinical trials include software and services. AI in clinical trial services encompasses the investigation and generation of insights from past and current clinical trials. Various processes, including trial design, patient selection, site selection, and patient monitoring, leverage technologies such as machine learning, deep learning, supervised learning, and other machine learning technologies. These applications span across various medical fields such as oncology, neurological diseases, cardiovascular diseases, metabolic diseases, infectious diseases, and immunology diseases. The end-users of AI in clinical trials include pharmaceuticals and biotechnology companies, contract research organizations, and others.

The AI in clinical trials market research report is one of a series of new reports from The Business Research Company that provides AI in clinical trials market statistics, including AI in clinical trials industry global market size, regional shares, competitors with AI in clinical trials market share, detailed AI in clinical trials market segments, market trends, and opportunities, and any further data you may need to thrive in the AI in clinical trials industry. This AI in clinical trials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The AI in clinical trials market size has grown exponentially in recent years. It will grow from $6.57 billion in 2024 to $9.21 billion in 2025 at a compound annual growth rate (CAGR) of 40.2%. The growth in the historic period can be attributed to data accumulation in healthcare, computing power advancements, FDA support for AI, rise of wearable devices, early AI algorithms development

The AI in clinical trials market size is expected to see exponential growth in the next few years. It will grow to $38.7 billion in 2029 at a compound annual growth rate (CAGR) of 43.2%. The growth in the forecast period can be attributed to real-world data integration, ai-powered patient recruitment, AI-driven biomarker identification, AI-driven trial design optimization, continuous monitoring technology. Major trends in the forecast period include federated learning approaches, AI in adaptive trials, AI-supported outcome prediction, ai-driven drug development, ai-powered drug repurposing.

The increasing prevalence of chronic and infectious diseases is expected to drive the growth of the AI in clinical trials market in the future. Chronic diseases are defined as illnesses that persist for three months or longer and can worsen over time. The application of artificial intelligence in clinical trials is beneficial for developing various drugs aimed at treating chronic conditions. For example, in June 2022, data released by Macmillan Cancer Support, a UK-based cancer charity, indicated that the number of individuals living with cancer reached 3 million in 2022 and is projected to rise to nearly 3.5 million by 2025 and 4 million by 2030 in the UK. Furthermore, in August 2024, the UK Health Security Agency, a UK-based executive agency, reported 368 cases of measles in England for 2023, which represents a nearly sevenfold increase from the 53 cases reported in 2022, with the West Midlands and London contributing to 44% and 33% of the cases, respectively. Therefore, the rising incidences of chronic and infectious diseases are driving the growth of the AI in clinical trials market.

The burgeoning pharmaceutical sector is anticipated to be a driving force behind the expansion of AI implementation in the clinical trials domain. This sector encompasses the discovery, development, and manufacturing of drugs and medications by governmental and private entities alike. Artificial intelligence integration within clinical trials within the pharmaceutical industry serves to heighten efficiency, hasten drug development processes, and refine decision-making protocols. AI technologies meticulously analyze extensive datasets, forecast patient responses, identify suitable trial participants, and optimize trial frameworks, resulting in more cost-efficient and streamlined clinical trials. For instance, statistics from the European Federation of Pharmaceutical Industries and Associations (EFPIA) as of June 2023 indicate that the overall pharmaceutical production in Europe reached $384,200 million (€340,000 million) in 2022, marking an approximate 4.95% increase from $366,267 million (€323,950 million) in 2021. Consequently, the escalating expansion of the pharmaceutical industry is a driving force behind the growth of AI integration in the clinical trials sector.

The surge in technological advancements stands as a pivotal trend gaining traction within the AI in clinical trials market. Entities entrenched in this market segment are actively embracing novel technologies to fortify their standing. An illustrative instance is the introduction, in February 2023, by Lantern Pharma, a US-based clinical-stage oncology company, of its distinctive RADR artificial intelligence (AI) and machine learning (ML) platform. This innovation aims to revolutionize the cost, pace, and duration associated with discovering and developing oncology medications. The RADR advancements primarily focus on pioneering AI and ML methodologies tailored to craft antibody-drug conjugates (ADCs). These ADCs, comprised of precisely targeted antibodies linked to potent anti-tumor small molecules, offer promising treatment avenues for cancer.

Major players within the AI in clinical trials sector are embracing a strategic partnership approach to introduce enhanced research tools and workflow efficiencies, leading to augmented timelines and improved patient recruitment. Strategic partnerships signify a collaborative process wherein companies capitalize on each other's strengths and resources to achieve mutual advantages and success. An exemplification of this strategy occurred in February 2023 when a US-based pharmaceutical commercial company partnered with Haystack Health, a US-based software development enterprise. Their partnership aims to harness the potential of AI and Natural Language Processing (NLP) to expedite clinical trials, enhance patient recruitment, and diminish the screen failure rate, which incurs considerable time and financial costs. This collaboration intends to leverage clinical AI and pre-screening services to achieve these goals effectively.

In October 2022, Beckman Coulter Diagnostics, a clinical diagnostics company based in the United States, successfully acquired StoCastic LLC for an undisclosed amount. This strategic acquisition is poised to enhance evidence-based Clinical Decision Support (CDS) capabilities and leverage Beckman Coulter Diagnostics' biomarkers to generate improved decision-support insights. The integration of StoCastic's artificial intelligence expertise into Beckman Coulter Diagnostics' offerings aims to empower clinicians to make more informed decisions quickly, ultimately contributing to enhanced patient outcomes. StoCastic LLC, based in the United States, is an artificial intelligence company specializing in the development of healthcare software.

Major companies operating in the AI in clinical trials market include Intel, The International Business Machines Corporation (IBM), Koninklijke Philips N.V., ConcertAI, Samaa Technologies, Owkin Inc., Numerate, Neuroute, AiCure, Ardigen, Unlearn AI, PathAI, Exscentia, Aitia Infotech Pvt Ltd., Euretos, VeriSIM Life, Envisagenics, NURITAs, BioSymetrics, BioAge Labs Inc, Trials.Ai, Pharmaseal, Caylx, IQVIA

North America was the largest region in the AI in clinical trials market in 2024. The regions covered in the ai in clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ai in clinical trials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The AI in clinical trials market consists of revenues earned by entities by providing AI software solutions and platforms designed to assist in various aspects of clinical trials, such as trial design, patient recruitment, data collection, monitoring, and analysis, data analytics and insights, predictive modeling and simulation, regulatory compliance, and safety monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in clinical trials also includes sales of computer vision technology, cognitive computing, and machine translation technologies which are used in providing clinical trials. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

AI In Clinical Trials Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ai in clinical trials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ai in clinical trials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ai in clinical trials market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Offering: Software; Services
2) By Process: Trial Design; Patient Selection; Site Selection; Patient Monitoring
3) By Technology: Machine Learning; Deep Learning; Supervised Learning; Other Technologies
4) By Application: Oncology; Neurological Diseases And Condition; Cardiovascular Diseases; Metabolic Diseases; Infectious Diseases; Immunology Diseases; Other Applications
5) By End-User: Pharmaceuticals And Biotechnology Companies; Contract Research Organizations; Other End-Users
Subsegments:
1) By Software: Clinical Trial Management Systems (CTMS); Data Analytics Software; Predictive Analytics Tools; Patient Recruitment And Retention Software; Real-World Evidence Platforms
2) By Services: Consulting Services; Data Management And Analysis Services; Training And Support Services; Regulatory Compliance Services
Companies Mentioned: Intel; The International Business Machines Corporation (IBM); Koninklijke Philips N.V.; ConcertAI; Samaa Technologies
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r24635

1. Executive Summary

2. AI In Clinical Trials Market Characteristics

3. AI In Clinical Trials Market Trends And Strategies

4. AI In Clinical Trials Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global AI In Clinical Trials Growth Analysis And Strategic Analysis Framework

5.1. Global AI In Clinical Trials PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global AI In Clinical Trials Market Growth Rate Analysis
5.4. Global AI In Clinical Trials Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global AI In Clinical Trials Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global AI In Clinical Trials Total Addressable Market (TAM)

6. AI In Clinical Trials Market Segmentation

6.1. Global AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Software
Services
6.2. Global AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Trial Design
Patient Selection
Site Selection
Patient Monitoring
6.3. Global AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Machine Learning
Deep Learning
Supervised Learning
Other Technologies
6.4. Global AI In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Neurological Diseases And Condition
Cardiovascular Diseases
Metabolic Diseases
Infectious Diseases
Immunology Diseases
Other Applications
6.5. Global AI In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceuticals And Biotechnology Companies
Contract Research Organizations
Other End-Users
6.6. Global AI In Clinical Trials Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinical Trial Management Systems (CTMS)
Data Analytics Software
Predictive Analytics Tools
Patient Recruitment And Retention Software
Real-World Evidence Platforms
6.7. Global AI In Clinical Trials Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Consulting Services
Data Management And Analysis Services
Training And Support Services
Regulatory Compliance Services

7. AI In Clinical Trials Market Regional And Country Analysis

7.1. Global AI In Clinical Trials Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global AI In Clinical Trials Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific AI In Clinical Trials Market

8.1. Asia-Pacific AI In Clinical Trials Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China AI In Clinical Trials Market

9.1. China AI In Clinical Trials Market Overview
9.2. China AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India AI In Clinical Trials Market

10.1. India AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan AI In Clinical Trials Market

11.1. Japan AI In Clinical Trials Market Overview
11.2. Japan AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia AI In Clinical Trials Market

12.1. Australia AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia AI In Clinical Trials Market

13.1. Indonesia AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea AI In Clinical Trials Market

14.1. South Korea AI In Clinical Trials Market Overview
14.2. South Korea AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe AI In Clinical Trials Market

15.1. Western Europe AI In Clinical Trials Market Overview
15.2. Western Europe AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK AI In Clinical Trials Market

16.1. UK AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany AI In Clinical Trials Market

17.1. Germany AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France AI In Clinical Trials Market

18.1. France AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy AI In Clinical Trials Market

19.1. Italy AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain AI In Clinical Trials Market

20.1. Spain AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe AI In Clinical Trials Market

21.1. Eastern Europe AI In Clinical Trials Market Overview
21.2. Eastern Europe AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia AI In Clinical Trials Market

22.1. Russia AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America AI In Clinical Trials Market

23.1. North America AI In Clinical Trials Market Overview
23.2. North America AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA AI In Clinical Trials Market

24.1. USA AI In Clinical Trials Market Overview
24.2. USA AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada AI In Clinical Trials Market

25.1. Canada AI In Clinical Trials Market Overview
25.2. Canada AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America AI In Clinical Trials Market

26.1. South America AI In Clinical Trials Market Overview
26.2. South America AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil AI In Clinical Trials Market

27.1. Brazil AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East AI In Clinical Trials Market

28.1. Middle East AI In Clinical Trials Market Overview
28.2. Middle East AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa AI In Clinical Trials Market

29.1. Africa AI In Clinical Trials Market Overview
29.2. Africa AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. AI In Clinical Trials Market Competitive Landscape And Company Profiles

30.1. AI In Clinical Trials Market Competitive Landscape
30.2. AI In Clinical Trials Market Company Profiles
- 30.2.1. Intel Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. The International Business Machines Corporation (IBM) Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. ConcertAI Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Samaa Technologies Overview, Products and Services, Strategy and Financial Analysis

31. AI In Clinical Trials Market Other Major And Innovative Companies

31.1. Owkin Inc.
31.2. Numerate
31.3. Neuroute
31.4. AiCure
31.5. Ardigen
31.6. Unlearn AI
31.7. PathAI
31.8. Exscentia
31.9. Aitia Infotech Pvt Ltd.
31.10. Euretos
31.11. VeriSIM Life
31.12. Envisagenics
31.13. NURITAs
31.14. BioSymetrics
31.15. BioAge Labs Inc

32. Global AI In Clinical Trials Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The AI In Clinical Trials Market

34. Recent Developments In The AI In Clinical Trials Market

35. AI In Clinical Trials Market High Potential Countries, Segments and Strategies

35.1 AI In Clinical Trials Market In 2029 - Countries Offering Most New Opportunities
35.2 AI In Clinical Trials Market In 2029 - Segments Offering Most New Opportunities
35.3 AI In Clinical Trials Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer